Mast Therapeutics' Merger

Mast Therapeutics raised a round of funding on April 27, 2017. Investors include Savara.

Mast Therapeutics (NYSEMKT: MSTX), fka ADVENTRX Pharmaceuticals, is a biopharmaceutical company focused on in-licensing, developing, and commercializing proprietary product candidates primarily for th…

Articles about Mast Therapeutics' Merger: